SINGAPORE – IFF, a manufacturer of ingredients for the food, beverage, health, biosciences, and scent markets is expanding its footprint in the Asian region with a new Innovation Center in Singapore.
IFF, present in 14 countries across Greater Asia, has been operating in Singapore since 1969 and the Innovation Center is part of IFF’s network of more than 50 research, creative, and design centers around the world.
The first in its global network of research, creative, and application centers, the Innovation Center in the nation’s premier biomedical research hub, integrates the technologies, capabilities, and expertise of all four business divisions: Nourish, Health & Biosciences, Scent and Pharma Solutions.
The 11,000 sqm facility, IFF’s largest in the region, features more than ten creation, design, and analytical laboratories, a collaboration studio, and culinary and demo kitchens, providing customers with full sensory capabilities to support each stage of the process from ideation through commercialization.
The hub has one of the biggest dairy processing pilot plants in Southeast Asia, replicating large-scale industrial production processes.
The center also houses IFF’s global innovation center for fabric care powders and personal wash, the largest scent evaluation facility worldwide, and is the first IFF location to support all scent product categories.
Ramon Brentan, IFF Singapore Innovation Center site leader and vice president, Greater Asia regional general manager, Scent, IFF said: “In this integrated space, we will unlock cross-divisional synergies, fast-tracking innovation and accelerating new growth opportunities.
“We are very well positioned to offer a comprehensive portfolio for Asian consumers, offering end-to-end solutions that consumers love in food, beverage, health, biosciences, and scent. This center is a true powerhouse of innovation and will further strengthen our position as a strategic co-creation partner to our customers in Asia.”
The opening follows IFF’s newly operational Singapore Flexiblend plant in Tuas and marks the latest in the company’s nearly US$30 million investment into Singapore.
Officially opened on October 12, the Singapore Flexiblend plant is aimed at increasing the company’s supply robustness and providing customized biotechnology solutions catered to grain processing and animal nutrition and health customers in the region.
The two facilities are part of a series of aggressive investments IFF is making to accelerate innovation, broaden its co-creation capabilities, drive speed to market and enhance accessibility to customers across Asia.
Frank Clyburn, chief executive officer of IFF noted that by 2030, Asia is projected to account for 60 percent of global economic growth. For IFF, Asia has demonstrated consistent growth, and we see tremendous opportunities in the future.
Just this year, IFF has opened innovation centers in the U.S., Latin America, Europe, and now Singapore, demonstrating its commitment to advancing scientific discovery globally.
Together, Clyburn said, these significant investments will fast forward innovation across the company’s broad portfolio, supporting its customers in creating differentiated, new-to-world solutions that benefit people and the planet.
For all the latest food industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube page, follow us on Twitter and LinkedIn, and like us on Facebook.